Patient Daily
  • Breakthrough
  • Community
  • People
  • Public Policy
  • Regulatory
  • Technology
  • Breakthrough
  • Community
  • People
  • Public Policy
  • Regulatory
  • Technology
  • Home
  • »
  • Stories
  • »
  • Massachusetts
  • EPIZYME, INC.: Announces Registration Path for Tazemetostat for Follicular Lymphoma and Provides Pipeline Updates and 2019 Guidance

    Regulatory
    Press release submission | Jan 5, 2019

    Epizyme, Inc. (Nasdaq: EPZM), a clinical-stage company developing novel epigenetic therapies, announced a comprehensive set of pipeline updates, including that the company has identified a path to submission for accelerated approval of tazemetostat for patients with relapsed and/or refractory follicular lymphoma (FL), both with and without EZH2 activating mutations.

  • RIBON THERAPEUTICS: Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer

    Breakthrough
    Press release submission | Jan 5, 2019

    Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions, announced the closing of a $65 million Series B financing. Proceeds will be used to advance lead programs from the company’s growing pipeline into clinical testing, including small molecule monoPARP inhibitors.

  • PARTNER THERAPEUTICS: Receives FDA Orphan Drug Designation for Leukine® for the Treatment of Pulmonary Alveolar Proteinosis

    Regulatory
    Press release submission | Nov 7, 2018

    Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Leukine® (sargramostim), a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhu-GM-CSF), for the treatment of pulmonary alveolar proteinosis (PAP).

  • ABBOTT: Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

    Breakthrough
    Press release submission | Oct 26, 2018

    New Assays empower Clinicians to more quickly make the right diagnosis at the point-of-care and prescribe the right treatment

  • ABBOTT: New Study Shows Abbott's Novel Diagnostic Test has the Potential to Demonstrate Gold Standard Accuracy and Speed, Which Could Help Rule Out Heart Attacks Earlier at the Point of Care

    Breakthrough
    Press release submission | Oct 18, 2018

    For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack.

  • IDEAS42: Massachusetts General Hospital and ideas42 join forces to identify new ways to support patients with opioid use disorder

    Press release submission | Aug 23, 2018

    Massachusetts General Hospital (MGH) and ideas42, a nonprofit behavioral design lab, announced a new research collaboration aimed at supporting patients in emergency care seeking treatment for Opioid Use Disorder (OUD).

  • MASSACHUSETTS GENERAL HOSPITAL: Under pressure: ResQFoam stops the bleed

    Breakthrough
    Press release submission | Jul 31, 2018

    Thirty-six minutes.

  • PIONEER INSTITUTE: Kudos To CHIA On Major Step Toward Greater Healthcare Price Transparency

    People
    Press release submission | Jul 31, 2018

    Pioneer applauds the Center for Health Information and Analysis (CHIA) on its recent release of all data behind its consumer facing CompareCare pricing tool for Massachusetts consumers.

  • MASSACHUSETTS GENERAL HOSPITAL: Study analyzes opioid overdose risk during pregnancy, postpartum period, among Mass. women

    People
    Press release submission | Jul 20, 2018

    A study of women giving birth in Massachusetts found a higher level of opioid use disorder than have studies conducted in other states.

  • MASSACHUSETTS GENERAL HOSPITAL: Prenatal exposure to folic acid fortification of foods may reduce mental illness risk

    People
    Press release submission | Jul 4, 2018

    Fortifying grain-based foods with folic acid – instituted in the U.S. in the 1990s to prevent neural tube defects in infants – may also reduce the incidence of severe mental illnesses like schizophrenia that initially appear in young adulthood.

  • MASSACHUSETTS GENERAL HOSPITAL: Maternal fatty acid balance affects offspring obesity thorough gut microbial population

    Breakthrough
    Press release submission | Jun 6, 2018

    The balance between omega-6 and omega-3 fatty acids in the tissues of female mammals, which previous research has suggested can impact the incidence of obesity in their offspring, appears to do so through its effect on the microbial population of the infant’s gastrointestinal tract.

  • MASSACHUSETTS GENERAL HOSPITAL: Keep the ticks off: Tips for protecting yourself

    People
    Press release submission | Jun 6, 2018

    The late spring and early summer are great times to get outside and hike, play sports or barbecue with family and friends.

  • MASSACHUSETTS GENERAL HOSPITAL: Virtual primary care visits for follow-up hypertension care have outcomes similar to office visits

    People
    Press release submission | May 29, 2018

    Virtual follow-up visits for patients with hypertension appeared to be just as effective as in-person office visits in helping maintain blood pressure control.

  • MASSACHUSETTS GENERAL HOSPITAL: Vascular risk factors interact with amyloid-beta levels to increase age-related cognitive decline

    Community
    Press release submission | May 23, 2018

    Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer’s-disease-associated changes in the brain.

  • MASSACHUSETTS GENERAL HOSPITAL: Automated system significantly improves identification of patients at risk for ventilator-associated pneumonia

    Technology
    Press release submission | May 22, 2018

    An automated system for identifying patients at risk for complications associated with the use of mechanical ventilators provided significantly more accurate results than did traditional surveillance methods, which rely on manual recording and interpretation of individual patient data.

  • MASSACHUSETTS GENERAL HOSPITAL: Our View: How to treat addiction like a chronic disease

    People
    Press release submission | May 22, 2018

    Have you ever heard an idea so good and obvious that you can’t believe it hadn’t been thought of before?

  • Cystic fibrosis sufferers, families and physicians push back at medication value study

    Public Policy
    John Breslin | May 17, 2018

    Cystic fibrosis sufferers, their families and physicians are fighting back against proposals that they claim could curb access to treatments.

  • MASSACHUSETTS GENERAL HOSPITAL: Artificial intelligence detects patterns of gut microbes that indicate cholera risk

    Breakthrough
    Press release submission | May 14, 2018

    Researchers from Massachusetts General Hospital (MGH), Duke University and the International Centre for Diarrheal Disease Research in Dhaka, Bangladesh, have used machine learning algorithms to spot otherwise undetectable patterns within communities of bacteria living in the human gut.

  • MASSACHUSETTS GENERAL HOSPITAL: State-of-the-art HIV drug could curb HIV transmission, improve survival in India

    Breakthrough
    Press release submission | May 8, 2018

    An HIV treatment regimen already widely used in North America and Europe would likely increase the life expectancy of people living with HIV in India by nearly three years and reduce the number of new HIV infections by 23 percent with minimal impact on the country’s HIV/AIDS budget.

  • MASSACHUSETTS GENERAL HOSPITAL: Imaging may allow safe tPA treatment of patients with unwitnessed strokes

    Press release submission | Apr 28, 2018

    Mismatch between two MRI methods could signify early stroke status, allowing use of "clot busting" drug

  • «
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • ...
  • 8
  • 9
  • »


Patient Daily Newsletter
Sign-up to receive news from Patient Daily


Trending

  • Brain stimulator produces positive, lasting results with almost no side effects
  • Novartis says Cosentyx better at clearing skin in psoriasis patients than Stelara
  • MODERNIZING MEDICINE: Dr. Michael Sherling, Chief Medical and Strategy Officer, to Speak with Surescripts at HIMSS about Enabling Price Transparency and Interoperability in Healthcare
  • NATIONAL KIDNEY FOUNDATION: New Home Test for Kidney Damage Shows Promising Results
  • TENNESSEE UROLOGY: Innovative Treatments For Female And Male Sexual Dysfunction & Sexual Health Conditions Prove Effective For Patients at Tennessee Urology

Patient Daily
  • About
  • Contact

Alerts Sign-up